Hypermucinous Dysplasia in Inflammatory Bowel Disease ( IBD ): Morphology, Molecular Features, and Its Place in the IBD ‐Associated Neoplastic Spectrum
Journal of Digestive Diseases · 2026-03 · 27 (3-4) · 110-117
DOI: 10.1111/1751-2980.70052 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Digestive Diseases, online erschienen am 20.05.2026. Verfasst von Ádám Ferenczi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Szeged, Szeged, Hungary. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colorectal Neoplasms, Precancerous Conditions, Intestinal Mucosa. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Szeged, Faculty of Medicine Postdoctoral Grant and Open Access Fund, Hungarian Academy of Sciences, University of Szeged, Open Access Fund.
Abstract (Originalsprache)
Long‐standing inflammatory bowel disease (IBD) increases the risk of dysplasia and colorectal cancer (CRC), particularly in patients with extensive disease or coexisting primary sclerosing cholangitis (PSC). Several non‐conventional dysplasia subtypes have been identified. Hypermucinous dysplasia was first formally proposed in 2020, and it arises predominantly in patients with long‐standing ulcerative colitis, frequently in extensive disease and concomitant PSC. Histologically, hypermucinous dysplasia is characterized by a tubulovillous or villous architecture lined by tall, prominent, mucin‐rich epithelial cells comprising more than 50% of the lesion, with minimal‐to‐mild cytologic atypia. Although often classified as low‐grade dysplasia according to previously established criteria, hypermucinous dysplasia is disproportionately associated with advanced neoplasia, including high‐grade dysplasia and CRC, and frequently coexists with both conventional and other non‐conventional dysplasias. Molecular alterations commonly include aneuploidy and occasional TP53 mutation. Emerging evidence suggests that non‐dysplastic, mucin‐rich epithelial proliferation, such as hypermucinous mucosa and foveolar metaplasia, may represent putative precursor lesions within a broader metaplasia–dysplasia sequence. This review provides the first comprehensive synthesis focusing exclusively on hypermucinous dysplasia, highlighting the consistency in histopathologic definitions, proposed precursor lesions, clinicopathological associations, molecular features, and diagnostic reproducibility. Increased awareness of hypermucinous dysplasia is essential for accurate diagnosis, risk stratification, high‐risk IBD population screening, and optimal management of patients with IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of Szeged, Szeged, Hungary.
- Department of Medical Physics and Informatics, University of Szeged, Szeged, Hungary.
ORCID-Profile: Ádám Ferenczi, Anita Sejben
Förderung
- University of Szeged, Faculty of Medicine Postdoctoral Grant and Open Access Fund
- Hungarian Academy of Sciences
- University of Szeged, Open Access Fund
- Szent-Györgyi Albert Orvostudományi Kar, Szegedi Tudományegyetem
- Magyar Tudományos Akadémia
- Szegedi Tudományegyetem
Zitieren
APA
Ferenczi, Á., Lantos, T., & Sejben, A. (2026). Hypermucinous Dysplasia in Inflammatory Bowel Disease ( IBD ): Morphology, Molecular Features, and Its Place in the IBD ‐Associated Neoplastic Spectrum. Journal of Digestive Diseases, 27(3-4), 110-117. https://doi.org/10.1111/1751-2980.70052
Vancouver
Ferenczi Á, Lantos T, Sejben A. Hypermucinous Dysplasia in Inflammatory Bowel Disease ( IBD ): Morphology, Molecular Features, and Its Place in the IBD ‐Associated Neoplastic Spectrum. Journal of Digestive Diseases. 2026;27(3-4):110-117. doi:10.1111/1751-2980.70052
BibTeX
@article{Ferenczi2026,
author = {Ferenczi, Ádám and Lantos, Tamás and Sejben, Anita},
title = {Hypermucinous Dysplasia in Inflammatory Bowel Disease ( IBD ): Morphology, Molecular Features, and Its Place in the IBD ‐Associated Neoplastic Spectrum},
journal = {Journal of Digestive Diseases},
year = {2026},
volume = {27},
number = {3-4},
pages = {110--117},
doi = {10.1111/1751-2980.70052}
}
EUVIMED